Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,533
archived clinical trials in
Chronic Obstructive Pulmonary Disease

Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Dublin, OH
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Dublin, OH
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Marion, OH
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Marion, OH
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Medford, OR
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Medford, OR
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis
mi
from
Portland, OR
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis
mi
from
Portland, OR
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Philadelphia, PA
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Tipton, PA
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Tipton, PA
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Carrollton, TX
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Carrollton, TX
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Channelview, TX
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Channelview, TX
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Fort Worth, TX
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Lampasas, TX
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Lampasas, TX
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
McKinney, TX
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
McKinney, TX
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
New Braunfels, TX
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
New Braunfels, TX
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Salt Lake City, UT
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Newport News, VA
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Newport News, VA
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Tacoma, WA
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Tacoma, WA
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Multiple Locations, AL
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Multiple Locations, AL
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Multiple Locations, AZ
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Multiple Locations, AZ
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Fort Lauderdale, FL
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Meridian, ID
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Meridian, ID
Click here to add this to my saved trials
Identifying Inflammatory Biomarkers of Chronic Obstructive Pulmonary Disease
Serum Inflammatory Biomarkers as Predictors of COPD Morbidity and Mortality
Status: Enrolling
Updated:  12/4/2017
Arizona Respiratory Center
mi
from
Tucson, AZ
Identifying Inflammatory Biomarkers of Chronic Obstructive Pulmonary Disease
Serum Inflammatory Biomarkers as Predictors of COPD Morbidity and Mortality
Status: Enrolling
Updated: 12/4/2017
Arizona Respiratory Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Tolerability of Metoprolol-Succinate-ER and Carvedilol in COPD
Randomized Open-Label Crossover Trial Comparing Tolerability of a Cardioselective Beta-Blocker (Metoprolol-Succinate-ER) and a Non-Cardioselective Beta-Blocker (Carvedilol) in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/7/2017
VA West Los Angeles Medical Center
mi
from
Los Angeles, CA
Tolerability of Metoprolol-Succinate-ER and Carvedilol in COPD
Randomized Open-Label Crossover Trial Comparing Tolerability of a Cardioselective Beta-Blocker (Metoprolol-Succinate-ER) and a Non-Cardioselective Beta-Blocker (Carvedilol) in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/7/2017
VA West Los Angeles Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Veteran's Administration Medical Center
mi
from
Birmingham, AL
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Veteran's Administration Medical Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
LA BioMed at Harbor-UCLA Medical Center
mi
from
Los Angeles, CA
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
LA BioMed at Harbor-UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
University of California at San Francisco
mi
from
San Francisco, CA
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
National Jewish Health
mi
from
Denver, CO
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
National Jewish Health
mi
from
Denver, CO
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Malcom Randall VA Medical Center
mi
from
Gainesville, FL
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Malcom Randall VA Medical Center
mi
from
Gainesville, FL
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
University of Illinois Health System
mi
from
Chicago, IL
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
University of Illinois Health System
mi
from
Chicago, IL
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
LSU Health
mi
from
New Orleans, LA
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
LSU Health
mi
from
New Orleans, LA
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
University of Maryland, Baltimore
mi
from
Baltimore, MD
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
University of Maryland, Baltimore
mi
from
Baltimore, MD
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Veteran's Administration Medical Center
mi
from
Boston, MA
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Veteran's Administration Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Reliant Medical Group
mi
from
Worcester, MA
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Reliant Medical Group
mi
from
Worcester, MA
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
University of Michigan
mi
from
Ann Arbor, MI
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Veteran's Administration Medical Center
mi
from
Ann Arbor, MI
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Veteran's Administration Medical Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Veteran's Administration Medical Center
mi
from
Minneapolis, MN
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Veteran's Administration Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
HealthPartners Research Foundation
mi
from
Minneapolis, MN
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
HealthPartners Research Foundation
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Lovelace Respiratory Research Institute
mi
from
Albuquerque, NM
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Lovelace Respiratory Research Institute
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Western New York Veterans Administration Healthcare System
mi
from
Buffalo, NY
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Western New York Veterans Administration Healthcare System
mi
from
Buffalo, NY
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Duke University
mi
from
Durham, NC
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Cincinnati VAMC
mi
from
Cincinnati, OH
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Cincinnati VAMC
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Cleveland Clinic
mi
from
Cleveland, OH
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Ohio State University
mi
from
Columbus, OH
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Oregon Health and Science University
mi
from
Portland, OR
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
St Luke'S Hospital And Health Network
mi
from
Bethlehem, PA
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
St Luke'S Hospital And Health Network
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Geisinger Medical Center
mi
from
Danville, PA
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Geisinger Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Institute for Respiratory and Sleep
mi
from
Langhorne, PA
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Institute for Respiratory and Sleep
mi
from
Langhorne, PA
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Temple University Lung Center
mi
from
Philadelphia, PA
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Temple University Lung Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
University of Pittsburgh
mi
from
Pittsburgh, PA
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Pittsburgh VA Medical Center
mi
from
Pittsburgh, PA
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Pittsburgh VA Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Baylor College of Medicine
mi
from
Houston, TX
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials